Is Pfizer a Smart Coronavirus Stock to Buy After Moderna's Great Vaccine Results?
The euphoria surrounding last week's news about tremendous efficacy results for the experimental coronavirus vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) didn't last long. On Monday, Moderna (NASDAQ: MRNA) upped the ante with even better results for its COVID-19 vaccine candidate, mRNA-1273.
Unsurprisingly, Pfizer stock slipped on Moderna's positive report. Is the big pharma still a smart coronavirus stock to buy after Moderna's great vaccine news?
Image source: Getty Images.
Source Fool.com